Help | RSS Feed



Insulet Corp. (NASD:PODD) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Insulet Corp. (NASD:PODD) seasonal charts above shows that a Buy Date of May 21 and a Sell Date of September 21 has resulted in a geometric average return of 14% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 11 of those periods. This is an excellent rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 5.95% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and a wireless personal diabetes manager that controls the dosage and has an integrated blood glucose meter. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 140,000-145,000 insulin-dependent diabetics are using it worldwide.

To download PODD seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore